Save your place

Sign in to WhoBought

Please try again later.

Hepion Pharmaceuticals, Inc. (HEPA) institutional ownership

Latest close $0.05 Jul 21, 2026
Market cap$523K 52-week range SectorHealthcare
Funds holding · Q4 2025
1
reported HEPA position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q4 2025
Activity unavailable N/A
0 buyers · 1 sellers

Hepion Pharmaceuticals, Inc. (HEPA) price and institutional activity

Dates

Q4 2025

$0 bought by 0 investors
$0 sold by 1 investors
Barclays PLC
Bought Sold Totals per quarter; hover a bar for the names.

Hepion Pharmaceuticals, Inc. (HEPA) institutional activity · 1

Investor Type Est. change Change Δ Own Date
Barclays PLC · Exited
Change −16 Δ Own −100.0% Date Q4 2025
Barclays PLC Exited· Q4 2025 −16 −100.0% Q4 2025
Data through Q4 2025 · filed Mar 19, 2026
1 of 1

Famous investor activity in Hepion Pharmaceuticals, Inc. (HEPA)

Hepion Pharmaceuticals, Inc. (HEPA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Purcell Michael J. · Director Buy +$50K
Price $0.04 Qty +1.2M Owned 1.2M Trade date Apr 21, 2026 Filed date Apr 27, 2026
Purcell Michael J. Director Buy $0.04 +1.2M +$50K 1.2M Apr 21, 2026 Apr 27, 2026
Lopriore Vincent S. · Director 2 operations +$250K
Price $0.04 Qty +6.2M Owned 6.2M Trade date Apr 21, 2026 Filed date Apr 27, 2026
Lopriore Vincent S. Director 2 operations $0.04 +6.2M +$250K 6.2M Apr 21, 2026 Apr 27, 2026
Appajosyula Sireesh · Director Buy +$50K
Price $0.04 Qty +1.2M Owned 1.2M Trade date Apr 21, 2026 Filed date Apr 27, 2026
Appajosyula Sireesh Director Buy $0.04 +1.2M +$50K 1.2M Apr 21, 2026 Apr 27, 2026
Stetz Gary S. · Director Buy +$50K
Price $0.04 Qty +1.2M Owned 1.2M Trade date Apr 21, 2026 Filed date Apr 27, 2026
Stetz Gary S. Director Buy $0.04 +1.2M +$50K 1.2M Apr 21, 2026 Apr 27, 2026
4 of 4

Hepion Pharmaceuticals, Inc. (HEPA) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Bigger Capital Fund L P 1.1M
% of shares outstanding 10.0% Filing date Jan 24, 2025
Bigger Capital Fund L P 1.1M 10.0% Jan 24, 2025
Anson Funds Management LP 576K
% of shares outstanding 4.9% Filing date Aug 14, 2025
Anson Funds Management LP 576K 4.9% Aug 14, 2025
S.h.n. Financial Investments Ltd. 0
% of shares outstanding 0.0% Filing date Aug 14, 2025
S.h.n. Financial Investments Ltd. 0 0.0% Aug 14, 2025
3 of 3

Hepion Pharmaceuticals, Inc. (HEPA) ownership FAQ

Who owns HEPA?

1 reporting institutions disclosed HEPA position changes in the Q4 2025 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q4 2025.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.